What is life science real estate and why are office REITs pivoting toward it?

Life science real estate: specialized laboratory, research, and office space used by biotechnology, pharmaceutical, medical device, and research institution tenants; 'wet lab' space requires specialized infrastructure — fume hoods, biosafety cabinets, lab benches, enhanced HVAC (for chemical and biological hazard control), high-power electrical capacity, specialized plumbing, and floor loading for heavy equipment; 'office/lab' buildings combine traditional office with wet lab space on alternating or intermingled floors; life science tenants typically include biotech startups (funded by venture capital), large pharma companies (research divisions), academic medical research centers, and clinical-stage drug development companies. Why office REITs are pivoting: life science space cannot be done remotely — lab work requires physical presence with specialized equipment; this structural work-from-anywhere immunity is exactly what office landlords need after COVID demonstrated that traditional office work can be remote; life science tenants tend to sign longer leases (10-15 years) because the cost of lab buildout (tenant improvements for wet lab can cost $200-400/sq ft vs. $50-100/sq ft for regular office) creates tenant stickiness; demand for life science space grew dramatically with COVID (pandemic vaccine/therapeutic research) and venture capital funding into biotech. Key life science clusters: Boston/Cambridge (Kendall Square), San Francisco/Bay Area (Mission Bay, South San Francisco), San Diego (Torrey Pines/UTC), Raleigh/Durham (Research Triangle), Seattle (South Lake Union); KRC's San Diego and San Francisco life science exposure is in two of the most established clusters.

What is a flight-to-quality trend in office real estate?

Flight-to-quality definition: a market dynamic where tenants upgrade the quality of their office space even as they reduce total square footage; companies consolidating from multiple offices into one choose to stay in (or move to) the best available building in the best submarket, even at a higher per-square-foot rent, because the total cost is still lower (less total space); alternatively, companies use return-to-office mandates as an opportunity to upgrade their space to attract employees back to the office. Mechanism: 'Class A' office buildings (premium location, modern construction, high ceilings, abundant natural light, excellent amenities like fitness centers, conference facilities, food halls, outdoor terraces) outperform 'Class B and C' buildings (older, less amenitized, less well-located) in terms of occupancy and rent growth; Class B/C buildings often struggle to retain tenants as leases expire because tenants use expiration as an opportunity to upgrade or consolidate. Winners and losers: BXP's trophy assets (the General Motors Building, Salesforce Tower, 601 Massachusetts Avenue) are among the most desirable buildings in their markets; they compete directly for the most creditworthy corporate tenants; flight-to-quality benefits these best-in-class assets at the expense of mediocre buildings; commodity office buildings in secondary locations face existential challenges (vacancy, potential conversion to residential, or obsolescence). Limitations: flight-to-quality does not solve the fundamental demand reduction — if companies are taking 30% less office space, even if it's all Class A space, the Class A market absorbs some of the demand destruction; total demand for Class A space has still fallen post-COVID, just less than Class B/C demand.

How do office REIT valuations reflect current market concerns?

Price-to-NAV discount: office REITs have been trading at significant discounts to estimated Net Asset Value (the estimated fair market value of properties minus debt); KRC and BXP have both traded at 30-50% or greater discounts to analyst NAV estimates; this discount reflects investor skepticism about (1) the accuracy of NAV estimates (are property values really as high as analysts estimate?) and (2) the ability to maintain NOI given post-COVID leasing headwinds. Cap rate expansion: office building sales have occurred at higher cap rates than pre-COVID (a 5% pre-COVID cap rate implies a property is worth 20x its NOI; a 7% post-COVID cap rate implies 14x NOI — a 30% price reduction for the same NOI); if current office transaction cap rates are applied to KRC and BXP's NOI, NAVs could be 20-40% below pre-COVID levels; some analysts argue office cap rates haven't fully reflected the new normal and current 'book' valuations overstate true asset values. Dividend analysis: KRC and BXP have both reduced dividends from peak levels to preserve cash flow amid occupancy uncertainty; office REIT dividend yields (based on current, reduced dividends) range from 5-8%, but investors question whether dividends are sustainable if occupancy continues to erode. Recovery vs. secular decline debate: bulls argue office REITs are dramatically oversold and that post-COVID office demand normalization will drive significant share price recovery; bears argue hybrid work has permanently reduced office demand and that office REIT book values don't yet reflect the magnitude of the structural change; this debate is the primary driver of office REIT price volatility.

Last updated: August 4, 2026

brimindinvest.com / compare / krc-vs-bxpLIVE

KRC

Kilroy Realty Corporation · Real Estate - Office

$38.82

-0.87% this month

VERSUS

⟷

COMPARE

BXP

BXP, Inc. (formerly Boston Properties) · Real Estate - Office

$70.41

+1.57% this month

Scoreboard verdict

Across AI score, momentum, valuation, upside, operating margin

KRC

1

BXP

3

BXP LEADS 3/5

Comparison scoreboard

BXP LEADS 3/5

AI Score

KRC 24.4

BXP ✓25.9

1Y Return

KRC ✓+11.88%

BXP +8.96%

Fwd P/E

KRC 72.90

BXP ✓33.52

Target Up.

KRC +0.73%

BXP ✓+4.96%

Op. Margin

KRC N/A

BXP 28.84%

Metrics last refreshed: 8/4/2026

Quick take

KRC vs BXP Stock Comparison: AI Score, Valuation, Performance and Upside

KRC (Kilroy Realty) and BXP are both premier office REITs navigating the post-COVID office demand reset — Kilroy is the West Coast specialist expanding into life science with a technology-market tenant base, while BXP is the largest U.S. office REIT with trophy gateway city properties in Boston, New York, San Francisco, Washington DC, and Los Angeles — both facing unprecedented office vacancy challenges especially in San Francisco.

KRC vs BXP is West Coast technology and life science office REIT with creative market positioning (Kilroy's San Diego biotech, LA media, Seattle tech exposure with sustainability leadership and life science pivot — managing West Coast tech employment cyclicality) versus the largest U.S. office REIT with trophy gateway city assets (BXP's iconic Class A buildings in Boston, New York, and San Francisco serving Fortune 500 and financial sector tenants — flight-to-quality beneficiary with San Francisco exposure as primary risk).

Live analysis · updated 8/4/2026

BXP holds the edge across 3 of 5 key metrics in this comparison. KRC has delivered stronger 1-year price return (+11.88% vs +8.96%), though BXP has the better forward P/E setup (33.52x vs 72.90x for KRC). Analyst consensus implies meaningfully more upside for BXP (+4.96%) than for KRC (+0.73%).

Normalized 1Y performance

KRC

BXP

Recent returns

KRC

BXP

Analyst price targets & sentiment

KRC · 14 analysts

STRONG BUYHOLDSTRONG SELL

Hold (2.8/5.0)

Price target range

analyst low$31.00
analyst high$51.00
analyst mean$39.29
current price$38.82

+0.7% upside to analyst mean

BXP

Price target range

analyst mean$73.60
current price$70.41

+5.0% upside to analyst mean

Who should consider this stock?

KRC may suit investors who:

→Want West Coast premium office exposure with a growing life science component that is more defensive than pure-play technology office
→Value Kilroy's sustainability leadership (LEED, carbon neutrality) as increasingly important for ESG-focused corporate tenants in lease decisions
→Believe the West Coast technology market will recover and that KRC's San Diego life science exposure provides meaningful portfolio diversification

BXP may suit investors who:

→Want the largest, most liquid U.S. office REIT with trophy Class A assets in gateway cities that should be flight-to-quality beneficiaries as companies consolidate into fewer, better offices
→Believe Boston and New York office markets (BXP's strongest markets) will recover faster than West Coast tech markets, providing earnings stability
→See BXP's scale, development expertise, and trophy asset portfolio as providing superior competitive positioning in a structurally challenging office environment

Performance & AI score

Performance & AI score
Metric	KRC	BXP
AI score	24.4	25.9
AI rank	#3105	#2634
Latest close	$38.82	$70.41
1M return	-0.87%	+1.57%
6M return	+16.42%	+11.66%
1Y return	+11.88%	+8.96%

$10,000 invested — hypothetical growth (dividends reinvested)

How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?

$10,000 invested — hypothetical growth (dividends reinvested)
Period	KRC	BXP
1Y ago	$11.9K (+19.0%) started 2025-07-31	$10.71K (+7.1%) started 2025-08-04
5Y ago	$10.35K (+3.5%) started 2021-08-02	$9.18K (-8.2%) started 2021-08-05
10Y ago	$14.15K (+41.5%) started 2016-08-01	$10.81K (+8.1%) started 2016-08-05

Hypothetical — past performance does not guarantee future results.

Valuation & upside potential

Valuation & upside potential
Metric	KRC	BXP
Market cap	$4.58B	$12.5B
Trailing P/E	27.27	37.70
Forward P/E	72.90	33.52
Price/Sales	4.19	N/A
EV/Revenue	8.38	9.18
Analyst target	$39.29	$73.60
Target upside	+0.73%	+4.96%

Growth, profitability & risk

Growth, profitability & risk
Metric	KRC	BXP
Revenue growth	-6.00%	3.80%
Earnings growth	-70.20%	-23.20%
EPS growth	-70.20%	-23.20%
FCF margin	+65.61%	+29.18%
Operating margin	N/A	28.84%
Profit margin	15.47%	9.20%
ROIC proxy	3.43%	5.31%
Return on equity	3.43%	5.31%
Dividend yield	5.56%	3.99%
Beta	1.15	1.04
Debt/equity	85.62	211.63
Current ratio	1.10	1.69
Quick ratio	1.03	1.49

Drawdown & downside risk

Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.

1Y risk snapshot

KRC max drawdown35.32%

BXP max drawdown35.36%

KRC max wkly drop11.66%

BXP max wkly drop9.32%

5Y risk snapshot

KRC max drawdown64.91%

BXP max drawdown62.57%

KRC max wkly drop17.39%

BXP max wkly drop15.64%

10Y risk snapshot

KRC max drawdown66.55%

BXP max drawdown63.59%

KRC max wkly drop25.74%

BXP max wkly drop29.95%

Performance metrics by period

Performance metrics by period
Period	Metric	KRC	BXP
1Y	Growth	+11.88%	+7.10%
	CAGR	+11.89%	+7.12%
	Sharpe ratio	0.38	0.23
	Max drawdown	35.32%	35.36%
	Max daily drop	6.87%	6.54%
	Max wkly drop	11.66%	9.32%
5Y	Growth	-24.38%	-26.25%
	CAGR	-5.44%	-5.91%
	Sharpe ratio	-0.13	-0.16
	Max drawdown	64.91%	62.57%
	Max daily drop	8.88%	7.70%
	Max wkly drop	17.39%	15.64%
10Y	Growth	-17.48%	-29.14%
	CAGR	-1.90%	-3.39%
	Sharpe ratio	-0.04	-0.09
	Max drawdown	66.55%	63.59%
	Max daily drop	18.50%	17.20%
	Max wkly drop	25.74%	29.95%

Business comparison

Business comparison
Category	KRC	BXP
Company	Kilroy Realty Corporation	BXP, Inc. (formerly Boston Properties)
Sector	Real Estate - Office	Real Estate
Industry	N/A	N/A
Core business	Kilroy Realty Corporation is a West Coast-focused office REIT that owns, develops, and acquires premier office and life science properties in San Francisco, Los Angeles, San Diego, and Seattle. Kilroy's portfolio consists of approximately 17 million square feet of stabilized office and life science space. Kilroy has been a leader in sustainable real estate (LEED certification, carbon neutrality commitments) and has aggressively expanded into life science (wet lab, research) facilities, particularly in San Diego's Torrey Pines and San Francisco's Mission Bay submarkets. Kilroy's tenant base includes major technology companies (cloud, software, social media) and biotech/pharma tenants.	BXP Inc. (formerly Boston Properties) is the largest publicly traded office REIT in the United States by total market capitalization, owning and developing approximately 54 million square feet of premier office properties in Boston, New York City, San Francisco, Washington DC, and Los Angeles. BXP focuses on Class A trophy properties — the highest-quality, best-located office buildings in each market — serving Fortune 500 companies, major financial institutions, law firms, and government agencies as anchor tenants. BXP's portfolio includes iconic properties like the General Motors Building in New York, 601 Massachusetts Avenue in Washington DC, and Salesforce Tower in San Francisco. BXP renamed itself from Boston Properties to BXP in 2023 to reflect its multi-market identity.
Investor focus	Investors track Kilroy's same-store NOI growth, occupancy rates, life science vs. office tenant mix evolution, development pipeline lease-up progress, and West Coast technology sector employment trends.	Investors track BXP's leasing activity (square footage leased, starting rent, lease term), occupancy rates in each market, development pipeline lease-up, and management's commentary on demand trends from large enterprise tenants.

KRC strengths

→Life science real estate expansion provides diversification from pure-play technology office exposure — San Diego Torrey Pines and San Francisco Mission Bay life science clusters anchor long-term biotech/pharma tenant demand that is more resistant to remote work trends than traditional office
→Premier West Coast submarkets (SOMA San Francisco, Westside LA, UTC San Diego) command above-average rents from technology and media tenants willing to pay for location quality
→Sustainability leadership (LEED certification, carbon neutrality) is increasingly important to ESG-focused corporate tenants who use sustainability ratings as criteria in office selection

BXP strengths

→Trophy Class A assets in gateway cities command premium rents and retain tenants better than commodity office — in a flight-to-quality environment (post-COVID, companies are consolidating into fewer, better offices), BXP's best-in-class buildings are the beneficiaries
→Boston and New York are the strongest U.S. office markets — both cities have significant life science and financial services demand that partially offsets technology sector softness; Boston's Kendall Square biotech cluster provides BXP a natural life science tenant base
→Scale provides development and capital market advantages — BXP's balance sheet and development expertise (having developed iconic buildings for decades) provides competitive advantages in winning development opportunities

Risks to watch — KRC

→West Coast technology sector slowdown directly impacts Kilroy's tenant demand — San Francisco and Seattle office markets are heavily exposed to technology sector employment cycles; tech layoffs (2022-2023) and remote/hybrid work adoption reduced office utilization and lease renewal activity
→San Francisco office market vacancy rates have reached unprecedented levels (25%+) — San Francisco's office market is the most challenged major U.S. office market; Kilroy's Mission Bay and SOMA San Francisco properties face meaningful uncertainty at lease expiration
→Development projects begun during pre-COVID demand environment may require longer lease-up periods — Kilroy's development pipeline was designed for a pre-COVID leasing environment; post-COVID lease-up timelines are longer than historical norms

Risks to watch — BXP

→San Francisco exposure is the most significant risk — BXP owns significant San Francisco office space (including Salesforce Tower); the San Francisco office market has the highest vacancy rates in the U.S. and the most uncertain demand recovery timeline
→Office real estate faces structural demand headwinds from hybrid work — even BXP's trophy Class A assets aren't immune to the reduction in average space per worker that hybrid work creates; long-term space demand per tenant may be structurally lower
→High interest rate environment compresses REIT valuations and increases refinancing costs — office REITs are heavily leveraged; rising interest rates have increased BXP's debt service costs and compressed the valuation multiples investors apply to its earnings

Frequently asked questions

What happened: San Francisco's office market was the first and hardest-hit major U.S. office market post-COVID; the city's economy is disproportionately dependent on technology sector employment (social media, cloud computing, fintech, crypto); the technology sector had massive layoffs in 2022-2023 (100,000+ tech jobs eliminated in San Francisco Bay Area); simultaneously, remote and hybrid work became standard practice for technology companies; these two forces simultaneously reduced demand for San Francisco office space while increasing supply via sublease listings from companies reducing their footprints. Current conditions: San Francisco's direct office vacancy rate exceeded 25% by 2023 (compared to approximately 5% pre-COVID); available sublease space (companies listing their leased but unused space for others to rent) added another 5-10% of effective availability; market rents fell significantly from their peaks; major office towers were surrendered to lenders (One Market Plaza, 350 California); building sales at deep discounts to prior valuations set new comparable sales at 40-60% price reductions. Recovery timeline: most office market analysts expect San Francisco recovery to be slow (5-10 years to approach pre-COVID occupancy) given the structural shift in technology work patterns; AI company growth (OpenAI, Anthropic, Scale AI) provides some demand but is not sufficient to offset the scale of departures; some observers argue tech hiring normalization will eventually reabsorb supply; others argue hybrid work is permanent and SF office will structurally underperform other markets. Impact on KRC and BXP: both REITs have significant San Francisco exposure; management teams have generally written down expectations for near-term San Francisco NOI recovery and are not underwriting rapid improvement; the uncertainty around recovery timeline is the primary source of valuation discount for these REITs.

AI Prediction SignalNext 5 trading days

Members only

KRC

+2.8%BUY

BXP

+1.1%HOLD

Start Free Trial Log in

ML model trained on historical prices · 14-day free trial · No credit card required

Free public comparison

Want deeper AI forecasts?

This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.

Start Free Trial Read Investing Guides

More comparisons